Low-dose OKT3 is not effective in the treatment of steroid-resistant acute renal allograft rejections.
Lye
W C
WC
Department of Medicine, National University Hospital, Singapore.
Vathsala
A
A
Lee
W T
WT
Leong
S O
SO
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008212:Lymphocyte Depletion; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology; D017211:Treatment Failure
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine